The neuropathological examination of animal and human tissues has proven to be a necessary part of the study of prion diseases because it is essential that an accurate diagnosis be rendered to validate each set of experiments or questions and because an integrated neuropathological- neurochemical-histoblot approach is helping us understand the mechanisms underlying both their etiology and their pathogenesis. The basic service provided by the Neuropathology Core to the Program Project is to verify the diagnosis of prion disease and rule out other neurological disorders for both human (Projects V and VI) and animal (Projects II, III and IV) cases through neurohistological examination of central nervous system tissues. A second function is to establish a human brain bank to store specimens from sporadic, infectious and genetic forms of prion disease, specifically for Projects V and VI. The Neuropathology Core has a variety of computer-assisted image analysis programs which will be used to quantify PrPSC and PrPCJD on histoblots. Semiquantitative assessment of the degree of regional spongiform degeneration, reactive astrocytic gliosis and nerve cell loss will be provided for both animal and human cases. Finally, a variety of video-image capturing methods are available in the Neuropathology Core which will be used to generate hard copies of histoblots for the projects and to achieve histoblots and neuropathology images on magneto-optical disks.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG002132-18
Application #
6267183
Study Section
Project Start
1998-02-01
Project End
1998-12-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
18
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
O'Brien, Connor J; Droege, Daniel G; Jiu, Alexander Y et al. (2018) Photoredox Cyanomethylation of Indoles: Catalyst Modification and Mechanism. J Org Chem 83:8926-8935
Condello, Carlo; Lemmin, Thomas; Stöhr, Jan et al. (2018) Structural heterogeneity and intersubject variability of A? in familial and sporadic Alzheimer's disease. Proc Natl Acad Sci U S A 115:E782-E791
Woerman, Amanda L; Kazmi, Sabeen A; Patel, Smita et al. (2018) MSA prions exhibit remarkable stability and resistance to inactivation. Acta Neuropathol 135:49-63
Yang, Bing; Wu, Haifan; Schnier, Paul D et al. (2018) Proximity-enhanced SuFEx chemical cross-linker for specific and multitargeting cross-linking mass spectrometry. Proc Natl Acad Sci U S A 115:11162-11167
Irimata, Katherine E; Dugger, Brittany N; Wilson, Jeffrey R (2018) Impact of the Presence of Select Cardiovascular Risk Factors on Cognitive Changes among Dementia Subtypes. Curr Alzheimer Res 15:1032-1044
Nick, Mimi; Wu, Yibing; Schmidt, Nathan W et al. (2018) A long-lived A? oligomer resistant to fibrillization. Biopolymers 109:e23096
Woerman, Amanda L; Watts, Joel C; Aoyagi, Atsushi et al. (2018) ?-Synuclein: Multiple System Atrophy Prions. Cold Spring Harb Perspect Med 8:
Woerman, Amanda L; Kazmi, Sabeen A; Patel, Smita et al. (2018) Familial Parkinson's point mutation abolishes multiple system atrophy prion replication. Proc Natl Acad Sci U S A 115:409-414
Wang, Tuo; Jo, Hyunil; DeGrado, William F et al. (2017) Water Distribution, Dynamics, and Interactions with Alzheimer's ?-Amyloid Fibrils Investigated by Solid-State NMR. J Am Chem Soc 139:6242-6252
Giles, Kurt; Woerman, Amanda L; Berry, David B et al. (2017) Bioassays and Inactivation of Prions. Cold Spring Harb Perspect Biol 9:

Showing the most recent 10 out of 363 publications